Jean‐Emmanuel Kahn

9.6k total citations · 1 hit paper
100 papers, 2.6k citations indexed

About

Jean‐Emmanuel Kahn is a scholar working on Rheumatology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jean‐Emmanuel Kahn has authored 100 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Rheumatology, 46 papers in Surgery and 31 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jean‐Emmanuel Kahn's work include Eosinophilic Disorders and Syndromes (44 papers), Eosinophilic Esophagitis (31 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (17 papers). Jean‐Emmanuel Kahn is often cited by papers focused on Eosinophilic Disorders and Syndromes (44 papers), Eosinophilic Esophagitis (31 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (17 papers). Jean‐Emmanuel Kahn collaborates with scholars based in France, United States and Belgium. Jean‐Emmanuel Kahn's co-authors include Johannes Ring, Amy D. Klion, Gerald J. Gleich, Florence Roufosse, Marc E. Rothenberg, Hans‐Uwe Simon, Peter F. Weller, Lawrence B. Schwartz, Lanny J. Rosenwasser and Johannes Huss‐Marp and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Jean‐Emmanuel Kahn

82 papers receiving 2.6k citations

Hit Papers

Treatment of Patients with the Hypereosinophilic Syndrome... 2008 2026 2014 2020 2008 100 200 300 400

Peers

Jean‐Emmanuel Kahn
Jean‐Emmanuel Kahn
Citations per year, relative to Jean‐Emmanuel Kahn Jean‐Emmanuel Kahn (= 1×) peers Divi Cornec

Countries citing papers authored by Jean‐Emmanuel Kahn

Since Specialization
Citations

This map shows the geographic impact of Jean‐Emmanuel Kahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Emmanuel Kahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Emmanuel Kahn more than expected).

Fields of papers citing papers by Jean‐Emmanuel Kahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Emmanuel Kahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Emmanuel Kahn. The network helps show where Jean‐Emmanuel Kahn may publish in the future.

Co-authorship network of co-authors of Jean‐Emmanuel Kahn

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Emmanuel Kahn. A scholar is included among the top collaborators of Jean‐Emmanuel Kahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Emmanuel Kahn. Jean‐Emmanuel Kahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chaigne, Benjamin, C. Agard, Yannick Allanore, et al.. (2023). Mouth opening in systemic sclerosis: A longitudinal analysis from the French national cohort study. Journal of Internal Medicine. 294(4). 482–491. 1 indexed citations
2.
Tréfond, Ludovic, Laurent Guy, Claude Darcha, et al.. (2023). Efficacy of Mepolizumab for the Treatment of Eosinophilic Cystitis: A Report of 2 Cases. Journal of Investigational Allergology and Clinical Immunology. 34(3). 202–204.
3.
Groh, Matthieu, Laura Venditti, Émilie Chalayer, et al.. (2021). FIP1L1-PDGFRA-Associated Hypereosinophilic Syndrome as a Treatable Cause of Watershed Infarction. Stroke. 52(10). e605–e609. 5 indexed citations
4.
Béné, Johana, Sophie Gautier, Aurélie Grandvuillemin, et al.. (2020). Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database. OncoImmunology. 9(1). 1722022–1722022. 37 indexed citations
5.
Legendre, Paul, Zora Marjanovic, Marguerite Vignon, et al.. (2020). Utilization of intravenous or subcutaneous immunoglobulins in secondary immune deficiency (ULTIMATE): A retrospective multicenter study. Clinical Immunology. 215. 108419–108419. 16 indexed citations
6.
Kahn, Jean‐Emmanuel, et al.. (2018). High frequency of anti-protein Z antibodies in patients with anticardiolipin antibodies. Immunobiology. 223(12). 772–776.
7.
Goulenok, Tiphaine, Paul Achouh, David Saadoun, et al.. (2017). New insights on tuberculous aortitis. Journal of Vascular Surgery. 66(1). 209–215. 28 indexed citations
8.
Grignano, Éric, A. Mékinian, Thorsten Braun, et al.. (2016). Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: A series of 26 cases and literature review. Leukemia Research. 47. 136–141. 36 indexed citations
9.
Jachiet, M., Maxime Samson, Vincent Cottin, et al.. (2016). 015 Anti-IgE monoclonal antibody (omalizumab) in refractory and relapsing eosinophilic granulomatosis with polyangiitis: data from 17 patients. Journal of Investigative Dermatology. 136(9). S163–S163. 1 indexed citations
10.
Chambrun, Marc Pineton de, Philippe Charron, Danièle Vauthier‐Brouzes, et al.. (2015). Reversible Severe Eosinophilic Endomyocardial Fibrosis During Pregnancy. Medicine. 94(32). e1307–e1307. 2 indexed citations
11.
Terrier, Benjamin, Alexandre Karras, Jean‐Emmanuel Kahn, et al.. (2013). The Spectrum of Type I Cryoglobulinemia Vasculitis. Medicine. 92(2). 61–68. 125 indexed citations
12.
Ackermann, Félix, et al.. (2013). Melioidosis in a European traveler without comorbidities: a case report and literature review. International Journal of Infectious Diseases. 17(9). e781–e783. 14 indexed citations
13.
Klion, Amy D., Florence Roufosse, Jean‐Emmanuel Kahn, et al.. (2012). Long-term Safety And Efficacy Of Mepolizumab For The Treatment Of Hypereosinophilic Syndrome. Journal of Allergy and Clinical Immunology. 129(2). AB203–AB203. 1 indexed citations
14.
Freymond, N., et al.. (2011). Clonal expansion of T cells in patients with eosinophilic lung disease. Allergy. 66(11). 1506–1508. 7 indexed citations
15.
Terrier, Benjamin, Ivan Bièche, Thierry Maisonobe, et al.. (2010). Interleukin-25: a cytokine linking eosinophils and adaptive immunity in Churg-Strauss syndrome. Blood. 116(22). 4523–4531. 99 indexed citations
16.
Puéchal, Xavier, M. Debandt, Jean‐Marie Berthelot, et al.. (2010). Tocilizumab in refractory adult Still's disease. Arthritis Care & Research. 63(1). 155–159. 113 indexed citations
17.
Girszyn, N., J Leport, Laurent Arnaud, et al.. (2007). Maladie de Crohn à expression vulvopérinéale exclusive. La Presse Médicale. 36(12). 1762–1765. 4 indexed citations
18.
Kahn, Jean‐Emmanuel, N. Girszyn, & O Blétry. (2006). Orientation diagnostique devant une hyperéosinophilie. Hématologie. 12(3). 201–209.
19.
Kahn, Jean‐Emmanuel, et al.. (2006). Lombalgie aiguë révélant la résorption d'une nucléopathie calcifiante. La Revue de Médecine Interne. 27(7). 569–572. 2 indexed citations
20.
Levy, Gal, et al.. (1954). [Treatment of primo-secondary syphilis of the adult by 15,000,000 units of penicillin in single dose preceded by cyanide of mercury; statistics after a maximum follow-up of six years].. PubMed. 70(9-10). 268–77. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026